Gary P Sidgwick

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Low Density Lipoprotein

Molecular Docking

Transcription Factor

Oxidative Stress

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Gary P Sidgwick, Ria Weston, Ayman M Mahmoud, Andrew Schiro, Ferdinand Serracino-Inglott, Shikha M Tandel, Sarah Skeoch, Ian N Bruce, Alan M Jones, M Yvonne Alexander, Fiona L Wilkinson
Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells 13 (4) (2024)
Gary P Sidgwick, Ria Weston, Ayman M Mahmoud, Andrew Schiro, Ferdinand Serracino-Inglott, Shikha M Tandel, Sarah Skeoch, Ian N Bruce, Alan M Jones, M Yvonne Alexander, Fiona L Wilkinson
Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells 13 (4) (2024)
Gary P Sidgwick, Ria Weston, Ayman M Mahmoud, Andrew Schiro, Ferdinand Serracino-Inglott, Shikha M Tandel, Sarah Skeoch, Ian N Bruce, Alan M Jones, M Yvonne Alexander, Fiona L Wilkinson
Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells 13 (4) (2024)
Gary P Sidgwick, Ria Weston, Ayman M Mahmoud, Andrew Schiro, Ferdinand Serracino-Inglott, Shikha M Tandel, Sarah Skeoch, Ian N Bruce, Alan M Jones, M Yvonne Alexander, Fiona L Wilkinson
Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells 13 (4) (2024)